The UPC – Three Years in Cross-Border Medtech Patent Strategy in the New European Landscape

Frédéric Chevallier focuses his practice on intellectual property matters, and in particular brings extensive experience leading on cross-border patent patent litigation before the Unified Patent Court (UPC) as well as before French courts. He represents pharmaceutical innovators and high-tech companies in their complex multi-jurisdictional patent disputes including matters involving small molecules, antibodies, Supplementary Protection Certificates (SPCs), medical use claims, and standard essential patents.

He represents clients in infringement and validity proceedings before several central local and regional divisions of the Unified Patent Court, as well as before French courts, in the life sciences and technology, media, and telecommunications (TMT) industries.

His practice also encompasses trademark and copyright litigation, as well as transactional regulatory experience in the life sciences industry.

Provides comprehensive advice to companies in patent litigation, including litigation involving standard-essential patents (SEPs) and FRAND defenses, and on license negotiations.

Has extensive experience handling proceedings before the European Unified Patent Court (UPC), having handled a large number of cases there.

Provides advice in other areas of intellectual property law, drawing on his many years of experience.

Charles (Chuck) Larsen provides clients sophisticated multijurisdictional counsel in intellectual property portfolio strategy, including patent prosecution, transactions, and disputes, with a particular emphasis in bio medical engineering and life sciences. He is licensed to practice before the US Patent and Trademark Office (USPTO), the European Patent Office (EPO), and the courts of England and Wales.

He has extensive experience in transactional IP matters, including transaction structuring and portfolio due diligence for investments and acquisitions, and negotiating collaboration license agreements, joint ventures, and other strategic commercial contracts involving key IP assets.

He also actively supports and counsels on transatlantic disputes, including US District Court cases, Patent Trial and Appeal Board (PTAB) proceedings, Reexaminations, EPO Oppositions, and litigation in Europe’s Unified Patent Court.

Chuck has advised on a wide range of technology in engineering and life sciences, including medical technology, pharmaceuticals, microfluidics, drug delivery, machine learning, signal processing, combustion, and energy. In the medical technology sector, his experience has involved a wide range of technologies, including medical diagnostics, intravascular devices, respiratory systems, orthopedic implants, cellular therapy, tissue engineering, neuromonitoring, spine technology, electrical stimulation, healthcare informatics, DNA sequencing, software driven devices, and biologic manufacturing.